These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23496205)

  • 21. Topical glycopyrrolate reduces axillary hyperhidrosis.
    Baker DM
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2131-2136. PubMed ID: 27406319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical glycopyrrolate for patients with facial hyperhidrosis.
    Kim WO; Kil HK; Yoon KB; Yoon DM
    Br J Dermatol; 2008 May; 158(5):1094-7. PubMed ID: 18294315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
    Kumar MG; Foreman RS; Berk DR; Bayliss SJ
    Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical atropine sulfate for the treatment of axillary hyperhidrosis.
    Grimalt R; Domínguez Tordera P; Callejas MA
    J Cosmet Dermatol; 2006 Dec; 5(4):294-6. PubMed ID: 17716247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilated Pupil in a Patient With Hyperhidrosis.
    Micieli R; Micieli JA
    JAMA; 2019 Jul; 322(3):264-265. PubMed ID: 31219503
    [No Abstract]   [Full Text] [Related]  

  • 26. A medical alternative to the treatment of compensatory sweating.
    Cladellas E; Callejas MA; Grimalt R
    Dermatol Ther; 2008; 21(5):406-8. PubMed ID: 18844718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eccrine nevus affecting the forearm of an 11-year-old girl successfully controlled with topical glycopyrrolate.
    Dua J; Grabczynska S
    Pediatr Dermatol; 2014; 31(5):611-2. PubMed ID: 23534977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
    Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing pitted keratolysis: consider topical glycopyrrolate.
    Kontochristopoulos G; Sidiropoulou P; Tzanetakou V; Markantoni V; Platsidaki E; Agiasofitou E; Rigopoulos D; Gregoriou S
    Clin Exp Dermatol; 2019 Aug; 44(6):713-714. PubMed ID: 30515854
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
    Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
    Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
    Siscos SM; Figenshau K; Rajpara A
    J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
    [No Abstract]   [Full Text] [Related]  

  • 35. Mydriasis secondary to use of glycopyrrolate cream.
    Radotra A; Baneke A; Paul B
    Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169
    [No Abstract]   [Full Text] [Related]  

  • 36. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
    Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
    Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxybutynin for hyperhidrosis.
    Lefrandt JD; Maurer JM
    Neth J Med; 2007 Oct; 65(9):356. PubMed ID: 17954957
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
    Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
    Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok R; Drew J; Quiring J; Pariser DM
    J Am Acad Dermatol; 2019 Jan; 80(1):128-138.e2. PubMed ID: 30003988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic gustatory sweating successfully treated with topical glycopyrrolate: report of a case and review of the literature.
    Urman JD; Bobrove AM
    Arch Intern Med; 1999 Apr; 159(8):877-8. PubMed ID: 10219935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.